Monday, December 11, 2017 ASH News Daily Page A-13 ® (left) Nicole Hope Lopez and Claudio Macias Trevino have a serious discussion about their posters at the Promoting Minorities in Hematology Reception Saturday evening. (lower left) Panelists take questions during the Hematology Course Directors' Workshop on Sunday morning. (below) Dr. Manuel Odin De La Mora poses in front of a giant whale shark at the Georgia Aquarium during the Promoting Minorities in Hematology Presentations and Reception. T:10" S:9.5" Visit Booth 3143 to find out more. COULD THE HEMATOLOGIC ACTUALLY BE CANCER BPDCN? YOU JUST DIAGNOSED... What a signature triad of diagnostic markers can tell you.* CD4 BPDCN = blastic plasmacytoid dendritic cell neoplasm. *BPDCN diagnosis can include other markers, such as TCL1 and CD303 (BDCA2).1 Reference: 1. Reichard KK. Blastic plasmacytoid dendritic cell neoplasm: how do you distinguish it from acute myeloid leukemia? Surg Pathol Clin. 2013;6(4):743-765. doi:10.1016/j.path.2013.08.010. Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved. 12/2017 2017008 BPDCNinfo.com CD56 T:7" S:6.5" CD123